InterviewS019
Ep. #65 – Luis Elizondo & John Greenewald, Jr. – 1 on 1
AAWSAP/AATIP roles and disclosure limits are discussed by Elizondo in conversation with Greenewald.
Supplied transcript read3 sources for “UAP programs”
Results
ReportS7705
10 U.S.C. §119 — Special access programs: congressional oversight (2024 Edition)
The 2024 Edition of this oversight provision distinguishes case-specific withholding from supplying information and justification to committee leadership. Its annual-report wording also carries a termination note referring to December 2021. Cross-referenced provisions and later changes have not been collated, so current application remains unverified. This is historical statutory context for programme-access claims, not evidence that a UAP programme existed or anyone obtained access.
Complete returned historical section; current application unreviewedReportS7646
Ovarian Cancer Research Program — Teal Innovator for OCRP 2011: A Researcher’s Perspective, Garry Nolan
The public Defense programme booklet identifies Nolan as the OCRP2011 Teal Innovator. His perspective reports ovarian-cancer cohort classification and describes hoped-for clinical benefits. This documents a public biomedical programme association; it establishes no classified UAP approach or access.
Selected Nolan perspective and programme context readA curated public selection. Source review describes what was read; it does not establish that a claim is true. Our research approach